# GSK372475 Bioequivalence Study

> **NCT00488098** · PHASE1 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 66 (actual)

## Conditions studied

- Healthy Subjects
- Depressive Disorder

## Interventions

- **DRUG:** GSK372475

## Key facts

- **NCT ID:** NCT00488098
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-07
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 66 (ACTUAL)
- **Last updated:** 2012-06-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00488098

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00488098, "GSK372475 Bioequivalence Study". Retrieved via AI Analytics 2026-06-10 from https://api.ai-analytics.org/clinical/NCT00488098. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*